Zydus Lifesciences shares in focus after USFDA approval for Dasatinib tablets
- Posted on March 6, 2025
- By Business News Today
- 4 Views
Zydus Lifesciences shares in focus after USFDA approval for Dasatinib tablets
Zydus Lifesciences share price: With this approval, Zydus has obtained 415 regulatory clearances and filed 483 Abbreviated New Drug Applications (ANDAs) as of December 31, 2024, since FY 2003-04.
